Autologous Blood Products in Ridge Preservation
Clinical, Radiological, and Ultrasonographic Evaluation of Autologous Blood Products in Alveolar Ridge Preservation: A Randomized Controlled Clinical Trial
2 other identifiers
interventional
40
1 country
1
Brief Summary
This randomized controlled clinical trial aims to evaluate the clinical, radiographic, and ultrasonographic outcomes of alveolar ridge preservation using autologous blood products following tooth extraction. After tooth extraction, dimensional changes occur in both hard and soft tissues, which may negatively affect future implant or prosthetic treatments. This study investigates whether the application of Titanium Platelet-Rich Fibrin (T-PRF), combined with injectable Platelet-Rich Fibrin (i-PRF), can improve healing and reduce tissue changes. In this study, tooth extraction will be performed under local anesthesia using minimally invasive techniques. Autologous blood will be collected from the patient and processed by centrifugation to obtain T-PRF and i-PRF. The prepared materials will be applied to the extraction socket and stabilized with sutures. Healing will be monitored through clinical examinations, radiographic imaging, and ultrasonographic evaluations over a 6-month follow-up period. Possible risks include pain, bleeding, infection, and temporary discomfort, all of which are manageable with standard clinical care. The study is expected to contribute to the development of biologically based, minimally invasive treatment approaches that enhance tissue healing and support future dental treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
April 15, 2026
April 1, 2026
7 months
April 1, 2026
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Horizontal Bone Width Change (CBCT Analysis)
Evaluation of horizontal bone width in millimeters at standardized levels (1 mm, 3 mm, and 5 mm from the alveolar crest) using CBCT at baseline (immediately after extraction) and 6 months
6 month
Study Arms (2)
control
NO INTERVENTIONtest
ACTIVE COMPARATORInterventions
Following atraumatic tooth extraction under local anesthesia, autologous blood will be collected from the patient. Titanium platelet-rich fibrin (T-PRF) will be prepared by centrifugation of blood in titanium tubes, and injectable platelet-rich fibrin (i-PRF) will be obtained using a low-speed centrifugation protocol. The prepared i-PRF will be injected into the T-PRF membrane to create a combined autologous fibrin construct. This material will then be placed into the extraction socket to support clot stability and tissue regeneration, and the site will be sutured for stabilization. This approach combines the dense fibrin structure of T-PRF with the biological activity of i-PRF, aiming to enhance angiogenesis, soft and hard tissue healing, and preservation of alveolar ridge dimensions.
Eligibility Criteria
You may qualify if:
- Systemically healthy individuals with no medical conditions that could interfere with periodontal treatment, tooth extraction, or wound healing
- Absence of systemic diseases affecting blood coagulation and no use of anticoagulant medications
- No history of blood-borne infectious diseases
- Non-smokers
- Age ≥18 years
- Patients requiring extraction of a single-rooted tooth in the maxilla or mandible
- Availability of a pre-existing CBCT scan of the planned extraction site
- Extraction site suitable for implant placement
You may not qualify if:
- Presence of systemic diseases that may affect periodontal treatment, tooth extraction, wound healing, or increase the risk of complications
- Presence of bleeding or coagulation disorders, or use of anticoagulant therapy
- Presence of blood-borne infectious diseases
- Smoking habit
- Age \<18 years
- Psychological or mental conditions that may affect compliance with treatment or study participation
- Extraction sites not suitable for implant placement
- History of previous surgical intervention or compromised healing in the extraction site
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Çanakkale Onsekiz Mart University
Çanakkale, Turkey (Türkiye)
Related Publications (1)
Araujo MG, Lindhe J. Dimensional ridge alterations following tooth extraction. An experimental study in the dog. J Clin Periodontol. 2005 Feb;32(2):212-8. doi: 10.1111/j.1600-051X.2005.00642.x.
PMID: 15691354BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
April 1, 2026
First Posted
April 15, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
April 15, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share